Sign Up
OverviewAPI
Chinese cities are administering COVID-19 vaccines targeting the XBB variant to their residents due to its prevalence and increased risk to vulnerable populations. The Chinese Center for Disease Control and Prevention reports that all 7,646 cases were of the Omicron variant, with XBB being the most prevalent. Vaccines from Chinese companies like Walvax Biotechnology Co and CanSino Biologics Inc have been approved for emergency use in China and are effective against the XBB Omicron subvariant.

Ask a question